Your browser doesn't support javascript.
loading
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study.
Zhang, Jin-Xing; Chen, Yu-Xing; Zhou, Chun-Gao; Liu, Jin; Liu, Sheng; Shi, Hai-Bin; Zu, Qing-Quan.
  • Zhang JX; Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Chen YX; Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Zhou CG; Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Liu J; Department of Clinical Medicine Research Institution, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Liu S; Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Shi HB; Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Zu QQ; Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Hepatol Res ; 52(9): 794-803, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35698267
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article